Pharmaceutical Company Payments to Executive Board Members of Professional Medical Associations in Japan

Hiroaki Saito; Akihiko Ozaki; Yasuma Kobayashi; Toyoaki Sawano; Tetsuya Tanimoto

doi:10.1001/jamainternmed.2018.7283

Pharmaceutical Company Payments to Executive Board Members of Professional Medical Associations in Japan

JAMA Intern Med. 2019 Apr 1;179(4):578-580. doi: 10.1001/jamainternmed.2018.7283.

Authors

Hiroaki Saito¹, Akihiko Ozaki², Yasuma Kobayashi³, Toyoaki Sawano⁴, Tetsuya Tanimoto^{2

5}

Affiliations

¹ Department of Gastroenterology, Sendai Kousei Hospital, Sendai, Miyagi, Japan.
² Medical Governance Research Institute, Minato-ku, Tokyo, Japan.
³ Department of Anesthesiology, Jichi Medical University Saitama Medical Center, Saitama, Saitama, Japan.
⁴ Department of Surgery, Minamisoma Municipal General Hospital, Minamisoma, Fukushima, Japan.
⁵ Department of Internal Medicine, Navitas Clinic, Tachikawa, Tokyo, Japan.

Abstract

This analysis of data from pharmaceutical manufacturers assesses the extent and distribution of industry payments to the executive board members of professional medical associations in Japan.

Publication types

Multicenter Study
Research Support, Non-U.S. Gov't

MeSH terms

Administrative Personnel / economics*
Biopharmaceutics / economics*
Health Personnel / economics*
Humans
Japan
Retrospective Studies
Societies, Medical*